Business
Hikma Analyst and Investor Call
Hikma Analyst and Investor Call.
About this update from Hikma Pharmaceuticals Plc
[{"type":"text","content":"\n \nRNS Number : 6464O Hikma Pharmaceuticals Plc 10 February 2016 \n\n\n\n\n\n \nHikma to host investor and analyst conference call \n \nLondon, 10 February 2016 - Hikma Pharmaceuticals PLC (\"Hikma\") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing pharmaceuticals company, announces that Hikma management will host a conference call for investors and analysts today at 12:30pm UK time to discuss the revised terms for its previously announced acquisition of Roxane Laboratories.\n \nThe conference call can be accessed by dialling +44 (0)20 3139 4830, and the participant PIN code is 25497247#. An audio replay of the conference call will also be made available approximately two hours after the conclusion of the call. The audio replay can be accessed by dialling +44 (0)20 3426 2807 and entering the PIN code 668223#.\n \nSaid Darwazah, Chairman and Chief Executive Officer of Hikma, and Khalid Nabilsi, Chief Financial Officer of Hikma, will host the call.\n \n -- ENDS --\n \n \nEnquiries\nHikma Pharmaceuticals PLC \nSusan Ringdal, VP Corporate Strategy and Investor Relations +44 (0)20 7399 2760/ +44 7776 477050\nZeena Murad, Investor Relations Manager +44 (0)20 7399 2768/ +44 7771 665277\n \nFTI Consulting ...